Drug manufacturers divided over jury trial in Oklahoma case

Drugmakers that Oklahoma sued over their alleged role in the nation's deadly opioid crisis appear divided over whether they want their case tried before a judge or jury.

Johnson & Johnson filed a motion Tuesday seeking a jury trial. The request came after Attorney General Mike Hunter dropped some of the state's claims last week. The move triggered a request to have a judge, not a jury, decide the case.

Teva Pharmaceuticals USA and Allergan filed a motion indicating they don't object to a trial before a judge if the state agrees to certain conditions.

A hearing on the motions is set for Thursday.

Oklahoma settled with Purdue Pharma for $270 million in March in the first such agreement following a wave of nearly 2,000 lawsuits against the company that had threatened to push it into bankruptcy.